
|Articles|March 6, 2007
US launch of Visian TICL delayed
Staar Surgical has revealed that its Visian toric implantable collamer lens (TICL) is unlikely to receive FDA approval in 2007.
Advertisement
Staar Surgical has revealed that its Visian toric implantable collamer lens (TICL) is unlikely to receive FDA approval in 2007.
The FDA has decided that, since the TICL is a first-of-its-kind device, it should be submitted to the Ophthalmic Devices Panel of the Center for Devices and Radiological Health for evaluation.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
BL1332 misses primary end point in phase 2 post-PRK ocular pain study
2
FLORetina-ICOOR 2026: AI moves from the image to the trial, the clinic, and the operating room
3
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
4
Q&A: GLP-1 RAs and NAION, the case for a baseline exam
5











